Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03459365 · ClinicalTrials.gov registry record · NA
Euflexxa for the Treatment of Osteoarthritis
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03459365 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 30 participants.
The verdict
NCT03459365, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The effect of Euflexxa therapy for knee osteoarthritis on levels of inflammatory and degenerative synovial fluid bio-markers in patients with knee osteoarthritis
Interventions
- DEVICE Euflexxa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2018-07-09 |
| Est. Completion | 2021-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03459365
The ClinicalTrials.gov registry entry for NCT03459365 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Euflexxa is the first listed.
NCT03459365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03459365 about?
NCT03459365 is a clinical study titled "Euflexxa for the Treatment of Osteoarthritis". The effect of Euflexxa therapy for knee osteoarthritis on levels of inflammatory and degenerative synovial fluid bio-markers in patients with knee osteoarthritis
What is the current status of trial NCT03459365?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-07-09. Estimated completion is 2021-10-31.
What interventions are being tested in trial NCT03459365?
The interventions under investigation include: Euflexxa (DEVICE).
Who is sponsoring clinical trial NCT03459365?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.